In 2002, Stabile et al. first reported that ERα and ERβ are expressed in fibroblasts in NSCLC tissue and that both cancer cells and fibroblasts showed enhanced proliferation when treated with E2. Here, ESR2 is linked to non-small cell lung carcinoma.